Dymon Asia Capital (Singapore)’s Eli Lilly LLY Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.8M	Buy	+1,500	New	+$1.53M	0.08%	136
2026 Q1	–	Sell	-1,500	Closed	-$1.61M	–	276
2025 Q4	$1.61M	Buy	1,500 +1,000	+200%	+$956K	0.16%	131
2025 Q3	$382K	Sell	500 -2,500	-83%	-$1.86M	0.04%	222
2025 Q2	$2.34M	Buy	3,000 +2,200	+275%	+$1.71M	0.32%	60
2025 Q1	$661K	Buy	+800	New	+$666K	0.15%	97
2024 Q4	–	Sell	-500	Closed	-$443K	–	127
2024 Q3	$443K	Buy	500 +200	+67%	+$180K	0.12%	79
2024 Q2	$272K	Buy	+300	New	+$240K	0.07%	87

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s LLY Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) opened a new position in Eli Lilly (LLY) in Q2 2026: 1,500 shares worth $1.8M. The stake represents 0.08% of the portfolio and ranks #136 among its holdings. This is a return to the name: Dymon Asia Capital (Singapore) previously reported a position in LLY as recently as Q4 2025.

Dymon Asia Capital (Singapore) first reported a position in LLY in Q2 2024 and has held it in 7 quarters since. The position peaked at $2.34M in Q2 2025. 2,216 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Dymon Asia Capital (Singapore) held 1,500 shares of Eli Lilly worth $1.8M as of Q2 2026.
Eli Lilly was a new Dymon Asia Capital (Singapore) position in Q2 2026.
Eli Lilly made up 0.08% of Dymon Asia Capital (Singapore)'s portfolio in Q2 2026, its #136 holding.
Dymon Asia Capital (Singapore) first reported a position in Eli Lilly in Q2 2024 and has held it in 7 quarters since.
Dymon Asia Capital (Singapore)'s Eli Lilly position peaked at $2.34M in Q2 2025.
2,216 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.